Qiagen NV(QGEN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 25.59 | EPS (ttm) | 1.97 | Insider Own | 0.6% | Shs Outstand | 206.5M | Perf Week | 9.23% |
| Market Cap | 10.38B | Forward P/E | 19.19 | EPS next Y | 7.56% | Insider Trans | - | Shs Float | 204.8M | Perf Month | 13.08% |
| Enterprise Value | 11.23B | PEG | 2.97 | EPS next Q | 0.63 | Inst Own | 77.22% | Short Float | 3.75% | Perf Quarter | 22.66% |
| Income | 0.41B | P/S | 4.94 | EPS this Y | 2.56% | Inst Trans | -3.45% | Short Ratio | 2.31 | Perf Half Y | 31.19% |
| Sales | 2.10B | P/B | 3.1 | EPS next 5Y | 6.46% | ROA | 6.99% | Short Interest | 7.68M | Perf YTD | 12.16% |
| Book/sh | 16.26 | P/C | 13.09 | EPS past 3/5Y | -0.15% 3.6% | ROE | 11.93% | 52W High | -12.84% ($57.81) | Perf Year | 2.21% |
| Cash/sh | 3.85 | P/FCF | 23.19 | Sales past 3/5Y | -0.81% 2.25% | ROIC | 8.21% | 52W Low | 54.9% ($32.53) | Perf 3Y | 34.96% |
| Dividend Est. | $0.26 (0.52%) | EV/EBITDA | 15.62 | EPS Y/Y TTM | 9.52% | Gross Margin | 61.8% | Volatility(W/M) | 4% 3.1% | Perf 5Y | -6.64% |
| Dividend TTM | 0.35 | EV/Sales | 5.35 | Sales Y/Y TTM | 2.96% | Oper. Margin | 24.62% | ATR (14) | 1.41 | Perf 10Y | 95.85% |
| Dividend Ex-Date | 2026/7/7 | Quick Ratio | 2.31 | EPS Q/Q | 7.13% | Profit Margin | 19.49% | RSI (14) | 74.51 | Recom | 2.82 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.85 | Sales Q/Q | 0.28% | SMA20 | 9.45% ($46.04) | Beta | 0.58 | Target Price | $47.93 |
| Payout | 12.88% | Debt/Eq | 0.49 | Earnings | 2026/8/5 | SMA50 | 13.42% ($44.43) | Rel Volume | 2.15 | Prev Close | $50.22 |
| Employees | 5654 | LT Debt/Eq | 0.48 | EPS/Sales Surpr. | 3.61% 1.43% | SMA200 | 18.48% ($42.53) | Avg Volume(3M) | 3.33M | Price | $50.39 |
| IPO | 1996/6/28 | Option/Short | Yes/Yes | Trades | 24070 | Volume | 7,144,445 | Change | 0.34% |
🧫 This is a global life sciences and diagnostics company that provides molecular diagnostics and sample preparation and analysis technologies. It supplies kits and equipment for extracting and analyzing genetic information from samples, as well as diagnostic tests for tuberculosis and infectious diseases. The company's results are tied to recurring consumables demand and diagnostic and research demand, making it a diagnostics and life sciences play.
Over the past 1 year, roughly in the middle
13% below its 1-year high.
Traded more than usual. That is 215% of its average volume.
QGEN makes money exceptionally well
Of every $100 in sales, $24.62 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +2.6% this year.
Tap to view numbers
Within its industry, it looks cheap
Counting its debt, for $100 of yearly operating cash you would pay $1,562. Peers typically go for $2,566.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -6.6%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.52% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 77.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #17 of 44 in the industry
Based on market cap of $10B.
FAQ
What kind of company is QGEN?
QGEN belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of QGEN?
The market cap of QGEN is approximately $10.4B, ranking 899 within its sector.
Does QGEN pay dividends?
QGEN has a dividend yield of approximately 0.52%, with an annual dividend of $0.26.
What is the P/E ratio of QGEN?
QGEN has a P/E ratio of approximately 25.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for QGEN?
QGEN has recorded a 52-week high of $57.81 and a low of $32.53.
